ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

ADAP Adaptimmune Therapeutics PLC

1.04
0.01 (0.97%)
15 Jun 2024 - Closed
Delayed by 15 minutes

Adaptimmune Therapeutics Financial Summary

The current ADAP market cap is 1.42B. The company's latest EPS is USD -0.0835 and P/E is -12.10.

Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 47.6M5.13M7.32M231k5.68M
Operating Income 1.55M-22.94M-46.3M-28.32M-49.02M
Net Income 1.04M-21.39M-45.6M-47.92M-48.5M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 1.12M3.96M6.15M27.15M60.28M
Operating Income -138.62M-133.58M-157.85M-166.4M-118.3M
Net Income -137.17M-130.09M-158.09M-165.46M-113.87M
Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 288.08M342.98M296.64M282.62M258.01M
Total Liabilities 204.21M216.33M208.51M243.1M233.64M
Total Equity 83.88M126.65M88.13M39.51M24.38M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 181.54M451.14M469.55M328.92M282.62M
Total Liabilities 57.91M109.92M263.59M247.04M243.1M
Total Equity 123.64M341.23M205.96M81.88M39.51M
Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -37.28M-81.05M-126.2M-140.88M-31.95M
Investing 48.34M51.04M108.34M176.54M-358k
Financing 196k210k806k880k29.24M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -112.51M-53.59M10.73M-141.77M-140.88M
Investing 94.95M-278.92M75.8M89.14M176.54M
Financing 366k340.05M3.29M12.87M880k
Market Cap 1.42B
Price to Earnings Ratio -12.10
Price to Sales Ratio 22.85
Price to Cash Ratio 9.56
Price to Book Ratio 34.84
Dividend Yield -

Share Statistics

Shares Outstanding 1.36B
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change -
52 Week High -
52 Week Low -
Spread (Intraday) 0.17 (14.66%)

Company Info

Company Name Adaptimmune Therapeutics PLC
Address 60 jubilee avenue
oxfordshire OX14 4RX
Website https://www.adaptimmune.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock